Research on COVID-19, the cause of a rapidly worsening pandemic, has led to the
observation of laboratory derangements such as a propensity towards a hypercoagulable …

The outbreak of 2019 novel coronavirus disease (Covid-19) is deeply weakening the all
world, and particularly, the healthcare systems. Respiratory physicians are part of the first …

The thrombogenic potential of Covid-19 is recognised and we read with interest the case
series of 22 patients presented by Mueller-Peltzer and colleagues [1]. Their findings of …

Disordered coagulation, endothelial dysfunction, dehydration and immobility contribute to a
substantially elevated risk of deep venous thrombosis, pulmonary embolism (PE) and …

An increased incidence of thrombotic complications has been described in COVID-19
patients, particularly in those with severe disease and/or admitted to the intensive care unit …

SARS-CoV-2 infection is associated with an increased risk of venous thromboembolism
(VTE), which is common during active illness but unusual in milder cases and after healing …

Abstract The Coronavirus Disease 2019 (COVID 19) has been reported in almost every
country in the world. Although a large proportion of infected individuals develop only mild …

Background Venous thromboembolism (VTE) with the prevalence of pulmonary
microcirculatory thrombosis is considered a common complication of novel coronavirus …

In December 2019, China reported the first cluster of severe acute respiratory syndrome due
to a new coronavirus 2 (SARS-CoV-2)[1, 2]. The disease rapidly spread into a global …

Objectives Infection with the SARS-COV2 virus (COVID-19) may be complicated by
thrombotic diathesis. This complication often involves the pulmonary microcirculation. While …